Pacific Biosciences of California (PACB) Stock Analysis

Pacific Biosciences of California (PACB) is a publicly traded company in the HEALTHCARE sector. It trades at $1.58, carries a market capitalization of $490.75M. This page summarizes the public market data, fundamentals, and frequently asked questions for PACB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Pacific Biosciences of California currently has a Bullish sentiment score of 0.38.

About Pacific Biosciences of California

Pacific Biosciences of California, Inc. (PACB) is a leading biotechnology company based in Menlo Park, California, specializing in cutting-edge genomic sequencing technologies that are revolutionizing the field. By providing high-resolution sequencing systems, PACB supports a range of applications from genetic research to personalized medicine, catering to the needs of researchers and healthcare professionals alike. With a robust focus on research and development and a growing suite of innova...

GNG Research Analysis

GNG Research scores Pacific Biosciences of California (PACB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PACB.

Frequently Asked Questions

Does PACB pay dividends?

Pacific Biosciences of California (PACB) does not currently pay a regular dividend.

What is PACB's market cap?

Pacific Biosciences of California (PACB) has a market capitalization of $490.75M with a current stock price of $1.58.